Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+6.42%
Changement Mensuel
-13.43%
Evolution sur 6 mois
+346.15%
Changement Annuel
+256.92%
Clôture Précédente
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Volume
15
Marchés
Actions des Marchés US
Soins de Santé
IPSC
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.82 M
59.17 M
64.82 M
86.05 M
—
Valuation ratios
Enterprise value
876.43 M
209.81 M
188.61 M
28.46 M
-3.04 M
Price to earnings ratio
-5.36
-2.19
-1.6
-0.63
-6.12
Price to sales ratio
—
55.21
94.06
12.06
13.21
Price to cash flow ratio
-5.77
20.43
-2.38
-0.72
-1.82
Price to book ratio
1.3
0.95
1.14
0.49
0.65
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.22
0.27
0.38
0.36
0.6
Return on equity %
0.24
0.43
0.74
0.78
0.89
Return on invested capital %
179.14
271.7
318.66
240.44
419.32
Gross margin %
—
100
100
100
—
Operating margin %
—
2 574.17
6 556.87
2 096.48
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
2 518.41
6 115.12
1 920.87
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
14.57
10.72
9.92
1.5
30.16
Inventory turnover
—
—
—
—
—
Asset turnover
—
0.01
0.01
0.02
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0.02
0.01
0.01
—
—
Long term debt to total equity ratio
0.02
0.01
0.02
—
—
Per share metrics
Operating cash flow per share
2.75
0.24
1.53
1.4
1.33
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
6.88
5.46
2.99
2.41
7.67
Net current asset value per share
7.04
5.54
3.06
2.47
7.89
Tangible book value per share
12.23
5.24
3.2
1.62
7.69
Working capital per share
6.56
5.02
2.76
0.82
5.64
Book value per share
12.23
5.24
3.2
2.05
9.32
Nouvelles
TD Cowen initie la couverture de Century Therapeutics avec une recommandation d’achat
TD Cowen initiates Century Therapeutics stock rating at Buy
Clear Street réitère sa recommandation d’achat sur Century Therapeutics à 6,60€
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
L’objectif de prix de Century Therapeutics abaissé à 6,60€ par Clear Street
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors